Read next
GLP-1 Class Drugs Reshape Pharmaceutical Capital Allocation
Surging demand for metabolic therapies prompts massive capital investments in fill-finish manufacturing facilities.
How Much Exercise Do You Actually Need?
The official guidance has a number. What the research shows about the shape of the benefit curve is…
Digital Therapeutics Face Regulatory Hurdles in European Expansion
Reimbursement complexity and fragmented clinical validation standards slow adoption of prescription software applications.
FDA Streamlines De Novo Pathway for AI Diagnostic Algorithms
New regulatory guidance establishes standardized performance metrics for machine-learning medical software.
How to Do Google Plan for Therapists
If you’re a licensed therapist, you’ve probably wondered how to do Google My Business. This article will walk…
Insurers Restrict Coverage Criteria for GLP-1 Metabolic Therapies
Rising demand for weight-loss medications prompts healthcare payers to implement strict pre-authorization rules.